We would love to hear your thoughts about our site and services, please take our survey here.
1st March was terrible timing. Just look at this from the day before:
https://www.theguardian.com/business/2022/feb/28/uk-banks-shares-ftse-100-russia-sanctions-ukraine
This stock looks like an absolute gem of a find to me. Any research I do just backs this up. Great products and a sector that is due for lift-off as people come into an office less but expect a fully streamlined, not to mention more ‘designer’ experience when they do.
Nice post. Just to clarify, AVA6000 does not involve Affimers. Precision is a different platform.
I have heavily filtered trolls ever since joining LSE. I’m now stepping this up to include all that respond to them in an attempt to be able to spot anything actually worth reading on here. Lots of green boxes await!
Yes please. Perfect day for a BBQ. Roast them shorts!
This is absolutely awful news for all of our prospects, health and sanity but that long awaited re-rate should fire up tomorrow!
https://twitter.com/drericding/status/1432200392776028162?s=21
Breast implants controllable via an app.
Zubaida thinks so…
https://twitter.com/zubhaque/status/1426829958450761729?s=21
Personally I would never recruit a career finance director into an MD role anyway. Sometimes an MD carries a company, other times a company carries the MD. In the later case, getting them out is a positive. Equally may have been a resignation on personal grounds.
I think Richard Hughes and Christian Stephenson have us more than covered. Christian is surely the main man in terms of the HUA project.
Directors come and go for all manner of reasons.
Appears to be the way he operates. Director for a year or so then let others take over. Look here:
https://find-and-update.company-information.service.gov.uk/officers/X-sx6WqcC4SKMI2ucD-c4wJF_bQ/appointments
Sales into the EU / ROW will make us a f***ing fortune.
Cut and paste job. Many have received the same email.
Funnily enough if you evaluate a test using frozen samples you end up selecting tests that work well with frozen samples.
If only there was some way we could design an evaluation method that would help us select a test that works well with clinical samples…
Never mind golden death crosses, a nice RNS at 7am and it will be golden **** and balls territory.
Utter utter bollllocks.
Just ended. Only caught the last 20 seconds.
Had the exact same response from my MP (Tory). It is a total non-answer and an insult.
Is there a grammar thing here. A test that ‘has’ home use approval when the contract is signed might not have it right now?
Can anyone verify? Typos in the email don’t fill me with confidence. Hoping it is not an elaborate deramp.
Bear in mind here that ‘all NHS staff’ covers a wide range of professions including non-clinical roles. The new test must therefore either have an EUA or be approved for home use.
AffiDX would be perfect for this use case. Can anyone verify the email? No offence but always good to hear from multiple sources. My other half has NHS contacts so will ask her.